Department of Hematology, The Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241271334. doi: 10.1177/10760296241271334.
A new scoring system termed sepsis-induced coagulopathy (SIC) has been proposed to diagnose early sepsis-induced disseminated intravascular coagulation (DIC). This study performed DIC-related analyses in patients with confirmed SIC. Data from the intensive care unit (ICU) departments of the three hospitals between 2020 and 2022 were retrospectively analyzed. Finally, 125 patients with confirmed SIC were enrolled in the study. The diagnostic value of three widely used DIC criteria was assessed in patients with newly diagnosed SIC. In addition, the diagnostic and prognostic value of antithrombin (AT) was analyzed in patients with SIC. The Japanese Association for Acute Medicine DIC criteria (JAAM) exhibited the highest DIC diagnostic rate, while the mortality risk of SIC patients demonstrated a proportional increase with higher International Society on Thrombosis and Haemostasis (ISTH) and Chinese DIC scoring system (CDSS) scores. Low AT activity (<70%) in septic patients upon SIC diagnosis predicted a very high 28-day mortality rate, almost twice as high as in the normal AT activity (≥70%) group. A decreasing tendency in AT activity after clinical interventions was correlated with increased mortality. The area under the ROC curve (AU-ROC) of AT in DIC diagnosis was statistically significant when CDSS and ISTH were used as diagnostic criteria, but not JAAM. Each of the three DIC diagnostic criteria showed diagnostic and prognostic advantages for SIC. AT could be an independent prognostic indicator for SIC but demonstrated a relatively limited DIC diagnostic value. Adding AT to the SIC scoring system may increase its prognostic power.
一种新的评分系统,即脓毒症诱导的凝血障碍(SIC)评分系统,已被提出用于诊断早期脓毒症诱导的弥散性血管内凝血(DIC)。本研究对确诊 SIC 的患者进行了 DIC 相关分析。回顾性分析了 2020 年至 2022 年间三所医院 ICU 部门的数据。最终,纳入了 125 例确诊 SIC 的患者。评估了三种广泛使用的 DIC 标准在新发 SIC 患者中的诊断价值。此外,还分析了 SIC 患者中抗凝血酶(AT)的诊断和预后价值。日本急救医学会 DIC 标准(JAAM)的 DIC 诊断率最高,而 SIC 患者的死亡率随着国际血栓与止血学会(ISTH)和中国 DIC 评分系统(CDSS)评分的升高呈比例增加。SIC 诊断时脓毒症患者的 AT 活性(<70%)低预测 28 天死亡率极高,几乎是 AT 活性正常(≥70%)组的两倍。临床干预后 AT 活性呈下降趋势与死亡率增加相关。当 CDSS 和 ISTH 作为诊断标准时,AT 在 DIC 诊断中的 ROC 曲线下面积(AU-ROC)具有统计学意义,但 JAAM 则不然。三种 DIC 诊断标准均显示出对 SIC 的诊断和预后优势。AT 可能是 SIC 的独立预后指标,但对 SIC 的 DIC 诊断价值相对有限。将 AT 添加到 SIC 评分系统中可能会增加其预后能力。